Dr. Susan L. Rusnack, M.D.
Urology (Urology Physician)
8631 W 3rd St, Suite 715e
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 874
Licensed in California since 2014, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: Jefferson Medical College of Thomas Jefferson University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
CA license C128392 (first issued 2014; current) · NY license 236481
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
Medical groups
- Tower Urology Inc (13 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 874
- Services billed
- 25,886
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 14,601 | 58 |
| Detection test by nucleic acid for organism, amplified probe technique | 1,586 | 105 |
| Creatinine level to test for kidney function or muscle injury | 1,474 | 708 |
| Manual urinalysis test with examination using microscope, non-automated | 1,474 | 708 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,139 | 574 |
| Bacterial culture for aerobic isolates | 814 | 285 |
| Bacterial colony count, urine | 577 | 306 |
| Limited ultrasound scan of pelvis | 464 | 352 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 447 | 215 |
| Insertion of lower leg neurostimulator electrode | 391 | 46 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gemtesa (vibegron) Other prescribers in Los Angeles, CA | 415 |
| Estradiol Other prescribers in Los Angeles, CA | 354 |
| Myrbetriq (mirabegron) Other prescribers in Los Angeles, CA | 231 |
| Cephalexin Other prescribers in Los Angeles, CA | 193 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Los Angeles, CA | 166 |
| Methenamine Hippurate Other prescribers in Los Angeles, CA | 108 |
| Imvexxy (estradiol) Other prescribers in Los Angeles, CA | 98 |
| Tamsulosin Hcl Other prescribers in Los Angeles, CA | 62 |
| Cefuroxime (cefuroxime axetil) Other prescribers in Los Angeles, CA | 60 |
| Estring (estradiol) Other prescribers in Los Angeles, CA | 54 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 40 payments worth $1,217 in total to this clinician.
| AbbVie Inc. | $196 |
|---|---|
| Bluewind Medical | $169 |
| Sumitomo Pharma America, Inc. | $146 |
| Astellas Pharma US Inc | $130 |
| Telix Pharmaceuticals | $100 |
| Ferring Pharmaceuticals Inc. | $96.25 |
| Janssen Biotech, Inc. | $93.65 |
| Calyxo, Inc. | $55.19 |
| Food and Beverage | $1,117 |
|---|---|
| Education | $99.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Astellas Pharma US Inc Oct 13, 2025 | Education in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.